2019-001500-38
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of Linaclotide Administered Orally to Children, Ages 6 to 17 Years, With Functional Constipation (FC)
AbbVie Deutschland GmbH & Co. KG·EU Clinical Trials RegisterOngoing
Study focus
- Disease/Condition
- Functional Constipation
Sponsor & location
- Primary sponsor
- AbbVie Deutschland GmbH & Co. KG
- Funder
- AbbVie Inc.
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
1.Medical Conditions
ICD-10 classifications
ConstipationOther functional intestinal disordersFunctional intestinal disorder, unspecifiedOther specified functional intestinal disordersOther laxatives
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2019-001500-38
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2019-001500-38 through Pure Global AI's free database. This phase not specified trial is sponsored by AbbVie Deutschland GmbH & Co. KG and is currently Ongoing. The study focuses on Functional Constipation.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.